The localization of MARCKS (myristoylated, alanine-rich C-kinase substrate), a major specific substrate for protein kinase C, has been studied in the rat brain. Light microscopic immunocytochemistry and biochemical analysis demonstrated that the protein is widespread throughout the brain and enriched in certain regions, including the piriform and entorhinal cottices, portions of the amygdaloid complex, the intralaminar thalamic nuclei, the hypothalamus, the nucleus of the solitary tract, nucleus ambiguus, and many catecholaminergic and serotonergic nuclei. Electron microscopic analysis revealed immunoreactivity in axons, axon terminals, small dendritic branches, and occasionally in dendritic spines. In neuronal processes, immunoreactivity was particularly prominent in association with microtubules, but reaction product was also seen in cytosol and adjacent to plasma membranes.
No reaction product was observed in large dendrites, somata, or nuclei. A population of strongly immunoreactive glial cells was also observed.
Many of these glial cells were morphologically similar to microglial cells, although some resembled astrocytes.
In glial cells, both cytoplasm and plasma membranes were heavily labeled. The distribution of the MARCKS protein did not coincide precisely with the distribution of any of the subspecies of protein kinase C. The results indicate that the MARCKS protein is expressed in the majority of cell types in the CNS, and they suggest that the protein may be involved both in glial cell functions and in neuronal functions involving cytoskeletal elements in small dendritic branches and axon terminals.
Calcium/diacylglycerol-dependent protein kinase plays an important role in neuronal functions such as neurotransmitter release and ion channel activity and appears to be involved in certain types of neuronal plasticity such as long-term potentiation (Nishizuka, 1986; Kikkawa and Nishizuka, 1988; for review, see Kaczmarec, 1987) . Distinct phosphoproteins are presumed to mediate the pleiotropic effects of protein kinase C. An elongated, acidic protein of M,3 1,950, which upon SDS-PAGE displays an apparent molecular mass of 80-87,000 Da, has been identified as a major specific substrate for protein kinase C (Wu et al., 1982; Rozengurt et al., 1983; Walaas et al., 1983a, b; Albert et al., 1986 Albert et al., , 1987 Pate1 and Kligman, 1987) . This myristoylated, alanine-rich C-kinase substrate (MARCKS) protein (Stump0 et al., 1989 ) is particularly enriched in brain but displays a widespread tissue distribution (Albert et al., 1986; Blackshear et al., 1986) . Biochemical studies indicated that the protein is present in both membrane and cytosolic fractions (Walaas et al., 1983a, b; Albert et al., 1986 Albert et al., , 1987 Pate1 and Kligman, 1987) . In macrophages, a fraction of the protein is myristoylated Figure 1 . Immunoblot of rat brain homogenate with affinity-purified antibody. Antiserum against the MARCKS protein was affinity purified as described in Materials and Methods and was used to immunoblot a strip of rat brain cortical homogenate. Arrow indicates the MARCKS protein, which is the only immunoreactive band on the strip. a and is associated with membranes, while the phosphorylated form of the protein is found mainly in the cytosol (Aderem et al., 1988) . In isolated nerve terminals, phosphorylation of the MARCKS protein by protein kinase C leads to its translocation from membrane to cytosol (Wang et al., 1989) . Due to a lack of knowledge of the exact cellular localization of the protein, the functional and structural importance of these changes has been difficult to ascertain. The present study examines the regional and subcellular distribution of the MARCKS protein in rat brain by immunochemical and immunocytochemical methods. The data indicate that the protein is enriched in certain brain regions; it is most easily detected in axons, axon terminals, dendrites of small diameter, and dendritic spines. In addition, it is also present in distinct populations of glial cells.
Materials and Methods
Production and characterization of antibodies against the MARCKSprotein. The MARCKS protein was purified from rat brain according to the method described for bovine brain (Albert et al., 1987) . Antiserum against purified MARCKS protein was raised in a New Zealand rabbit as previously described (Albert et al., 1986) . Affinity purification of the antiserum was performed essentially according to the protocol of Olmsted (198 1). Briefly, 16 mg of rat brain cortical homogenates were subjected to SDS-PAGE, followed by electrotransfer onto nitrocellulose membranes and immunoblotting with the specific antiserum diluted 2-fold (Albert et al., 1986) . Antibodies bound to the MARCKS region of the blots were then eluted into a final volume of 5 ml (Olmsted, 198 1) and used for immunocytochemistry.
Two-dimensional gel electrophoresis showed that the antiserum did not crossreact with any proteins that corn&rated with the MARCKS protein upon SDS-PAGE (unpublished observations). The specificity of the affinitypurified antibody was confirmed by blots of brain homogenates in which only the MARCKS protein was recognized (Fig. 1 ).
Quantitative analysis of the MARCKSprotein.
Male Sprague-Dawley rats gm) were stunned, decapitated, and their brains were rapidly removed, cooled on ice, and dissected as described (Walaas et al., 1983a amounts of MARCKS protein in each sample, 2-200 pg of cortical synaptosomal protein were also immunoblotted to construct a "standard curve." This was used to convert the cpm value of each sample to a specific activity relative to the value in cerebral cortex synaptosomes. All data were then normalized to the highest value which was set at 100%.
Zmmunocytochemicalprocedures. Male Sprague-Dawley rats (150 gm) were anesthetized with chloral hydrate (350 mg/kg) and perfused with a cannula placed through the heart into the aorta. Fixatives containing either 4% formaldehyde (freshly depolymerized from paraformaldehyde) or 2% formaldehyde and 1.25% glutaraldehyde in 10 mM sodium phosphate buffer (pH 7.4) were found to give identical immunostaining patterns, but the mixture of formaldehyde and glutaraldehyde was chosen because it gave better morphological preservation at the electron microscopic level. For light microscopy, perfusion with 500 ml fixative was preceded by perfusion with 150 ml of 10 mM sodium phosphate buffer. This step was omitted for the electron microscopic studies.
Fixative was delivered at a pressure of 60 mm Hg with a peristaltic pump. Brains were allowed to postfix for 1 hr in situ and were then cut in the coronal plane into 3 mm slabs. The slabs were subsequently cut into 100 pm sections on a vibratome and collected in PBS containing 10 mM sodium phosphate and 0.15 M sodium chloride (pH 7.4). The sections were then immersed in sodium borohydride (1% in PBS) for 30 min, rinsed in PBS (3 x 15 min), and incubated with the affinitypurified antibody to the MARCKS protein (described above) for 18 hr at room temperature on a tissue shaker. Preliminary experiments, using dilutions of the antibody between 1: 10 and 1: 10,000 indicated that optimal immunostaining was achieved at a dilution of 1:25 (not shown). This dilution was used in subsequent studies.
Following incubation with primary antibody, the sections were washed in PBS (3 x '10 min) and incubated with the following components from a Vector ABC Kit (Vector Laboratories) according to their instructions: biotinylated horse antirabbit IgG (1: 100) for 1 hr, followed by avidin-biotin-HRP complex for 1 hr. PBS washes (3 x 10 min) were used between steps. The sections were immersed in 50 ml of 0.1 M sodium phosphate buffer containing 25 mg 3,3-diaminobenzidine and 10 pl of 30% H,O, for 2 min. For light microscopy, sections were then mounted on subbed slides, coverslipped with Permount, and examined. For electron microscopy, sections were osmicated in 2% osmium tetroxide in 0.1 M sodium phosphate buffer for 20 min, dehydrated in a graded series of ethanol solutions, and embedded in EMBED-S 12 (Electron Microscopic Sciences). Sections 80 nm thick were cut on an ultratome and examined in a JEOL 1OOcx electron microscope without prior staining in either lead citrate or uranyl acetate.
The specificity of the staining protocol was assessed by the substitution of the following for the primary antibody: (1) diluent without primary antibody, (2) normal rabbit serum, (3) serum antibodies directed against irrelevant antigens. None of these substitutions produced immunostaining similar to that of the primary antibody to the MARCKS protein.
In addition, omission of the secondary antibody or of the avidin-biotin-HRP complex led to a total lack of staining (not shown). Potential t Figure 4 . Photomicrographs of immunostaining for the MARCUS protein in coronal sections through the rat brain at the following levels: A, pontine nuclei; B, locus coeruleus; C, seventh cranial nerve; and D, nucleus tractus solitarius. These photomicrographs were prepared as for Figure 3 . CB, cerebellum; DTI, dorsal tegmental nucleus, pars lateralis; EC, external cuneate nucleus; IO, inferior olive; LC, locus coeruleus; NA, nucleus ambiguus; NTS, nucleus of the solitary tract; PB, parabrachial nucleus (dorsal portion); PBG, parabigeminal nucleus; PC, periaqueductal gray; PN, pontine nuclei; PrH, prepositus hypoglossal nucleus; Rcs, centralis superior raphe nucleus; SC, superior colliculus; 7n, seventh cranial nerve; arrow, dorsal raphe nucleus; arrowhead, paracentral dorsal tegmental nucleus. Scale bar, 1 mm.
Finure 5. Photomicrographs of elial cells (arrowheads) immunoreactive for the MARCUS nrotein in frontal cortex (AA). cinaulate cortex (BB). and hypothalamus (C, D). 1; kand Cl the glial cells are par&ally wrapped around neuronal cell bodies (arrows) that are ndt &m&oreactive.
Nb;i that the punctate immunostaining is greater in the hypothalamus (C, D) than in the cortical regions and that the processes containing the immunoreactivity are difficult to resolve. Scale bar, 10 pm. Immunoreactivity, which appears white, is stronger in layer IV than in other cortical layers. Immunoreactivity is also strong in layer I. This staining pattern is difficult to visualize without dark-field optics but can also be faintly seen throughout cortex in Figure 3 . I-VI signify the layers of neocortex as determined in a Nissl-stained adjacent section. Scale bar, 100 pm.
contamination of the primary antibody with antibodies against other antigens was avoided by affinity purification of the primary antibody as described above.
All light microscopic photomicrographs were taken with bright-field optics except for Figures 3, 4 , 6, and 9C.
Results

Irnmunoblotting
Immunoblotting analysis of the MARCKS protein in microdissected brain regions showed that the protein was widely but not homogeneously distributed (Fig. 2) . The highest levels of the MARCKS protein were found in the amygdala, ventral striatum, intralaminar thalamic nuclei, and hypothalamus. The lowest levels were found in the optic nerve and the pituitary and pineal glands (Fig. 2) . The brain stem and spinal cord also contained low levels of the protein (data not shown).
Light microscopy The distribution of the MARCKS protein observed by immunoblotting was consistent with that observed by light microscopic immunocytochemistry. Processes immunoreactive for the MARCKS protein were present throughout the brain, and immunostaining was more intense in some regions than in others (Figs. 3,4) . Most of the immunoreactivity was confined to small structures that appeared somewhat punctate but could not be further resolved at the light microscopic level (Figs. 5-10 ). In addition, a population of cells having small soma diameters (5-8 Km) and scant cytoplasm were immunoreactive (Fig. 5) . These small cells were morphologically similar to microglial cells, although some resembled astrocytes.
The strongest immunostaining was present in the piriform and entorhinal cortices, portions of the amygdaloid complex, portions of the ventral striatum, the intralaminar nuclei of the dorsal thalamus, nucleus reuniens, hypothalamus, portions of the medial geniculate nucleus, substantia nigra pars compacta, ventral tegmental area, parabigeminal nucleus, parabrachial nucleus, periaqueductal gray region, molecular layer of the cerebellum, locus coeruleus, raphe nuclei, nucleus of the solitary tract, nucleus ambiguus, external cuneate nucleus, nucleus pre- Figure 7 . Low-power photomicrographs of immunoreactivity for the MARCKS protein in the intralaminar thalamic nuclei (A) and hypothalamus (B). Note that the immunoreactivity is indistinct but that neurons are not immunoreactive. A, Intralaminar nuclei are more strongly immunoreactive than surrounding areas. In addition, the habenula (Ha) is strongly immunoreactive. B, Hypothalamus and nucleus reuniens (Re) are more strongly immunolabeled than adjacent structures such as the globose nucleus (G) and the ventromedial nucleus (VW) of the dorsal thalamus. The zona incerta (27) lies within a band of immunoreactivity that runs along the border between the hypothalamus and dorsal thalamus (compare with similar labeling associated with the pars compacta of the substantia nigra in Fig. 8B ). Insert shows greater detail of immunoreactivity in the median eminence. AR, arcuate nucleus; CL, centrolateral nucleus; CM, centromedial nucleus; f; fomix; IMD, intermediodorsal nucleus; ME, median eminence; ml, mammillothalamic tract; PV. paraventricular nucleus; Rh, rhomboid nucleus; VMH, ventromedial hypothalamic nucleus; 3 V, third ventricle.
Scale bar, 1 mm. In the piriform and entorhinal cortices (Fig. 3 , A-H) immunoreactivity was present in both the polymorph and molecular layers. Staining was less dense in the pyramidal layer because neuronal somata were unstained. In the amygdaloid complex, immunoreactivity was conspicuously weak or absent from the basolateral nuclei but strong in the remaining areas (Fig. 3, D-F) . In the dorsal thalamus, the intralaminar nuclei, especially the centrolateral, centromedial, interrnediodorsal, rhomboid, and paraventricular nuclei, were very strongly immunoreactive (Figs. 3, D-E; 7) . At caudal levels, however, the t Figure 8 . Low-power photomicrographs of immunoreactivity of the MARCUS protein in the midbrain. A, Immunoreactivity in the region of the ventral tegmental area (VA). Immunoreactivity is stronger in the ventral tegrnental area and in the paranigral (PNQ area than in surrounding regions. Immunoreactivity is also present to a lesser extent in the interpeduncular nucleus (ZPN). B, Immunoreactivity associated with the substantia nigra and medial geniculate nucleus. The substantia nigra pars compacta (SW) lies within a band of immunoreactivity that extends from the VTA dorsolaterally to the outer portions of the medial geniculate nucleus. The dorsal (MGD) and medial (MGM) subdivisions of the medial geniculate nucleus are more immunoreactive than the ventral subdivision (MGV). (Compare these photomicrographs with the lower-power photomicrograph in Fig. 3H ). SNR, substantia nigra pars reticulata; closed arrow, dorsal surface of brain. Scale bars, 100 pm. Figure 10 . Photomicrograph of immunoreactivity for the MARCKS protein in the hilus fasciae dentatae (Hi) of the hippocampus. Immunoreactivity is stronger in the hilus than in the dentate gyms (above and below the hilus in this photomicrograph). The granule cells (Gr) are notably nonimmunoreactive, while many immunoreactive glial cells are present in both the hilus and the dentate gyms (arrowheads). Scale bar, 100 Wm. staining in the centrolateral nucleus was greatly reduced. Immunostaining was also very intense in the nucleus reuniens.
Strong immunoreactivity was present throughout the hypothalamus (Figs. 3, D-G; 5D ; 7B). The ventromedial and arcuate nuclei, however, were less immunoreactive than neighboring hypothalamic regions. A band of very heavy immunoreactivity was present in the inner third of the median eminence (Fig. 7) .
In the midbrain, broad bands of strong immunoreactivity were associated with the medial geniculate nucleus, the interpeduncular nucleus, and the substantia nigra (Fig. 8) . The substantia nigra pars compacta, medial and dorsal portions of the medial geniculate nucleus, paranigral nucleus, peripeduncular nucleus, and ventral tegmental area were included in the areas covered by these immunoreactive bands, which crossed borders rather than following the limits of specific nuclei (see, for example, the substantia nigra pars compacta in Fig. 8B ).
Strong immunoreactivity in the cerebellum was confined to the molecular layer (Figs. 4, B, C, 9 ). Purkinje cell somata were unstained as were their primary and secondary dendrites, which could be followed through much of the molecular layer.
Immunostaining was not prominent in the hippocampal formation. Of the various hippocampal regions, the strongest immunostaining was present in the hilus (Figs. 3, D-H, 10) . The cell bodies of granule cells were noticeably not immunoreactive. In contrast, numerous glial cells were strongly immunoreactive.
Electron microscopy Three regions were examined at the ultrastructural level: the hypothalamus, the cingulate cortex, and the hippocampus (CAl).
Immunostaining was similar in all 3 areas. In neurons, immunoreactivity was found in axons, axon terminals, small dendritic branches (0.5-0.8 pm diameter), and occasionally in den- dritic spines (Figs. 11-14) . Neuronal somata, nuclei, and large dendrites (> 0.8 pm in diameter) were not immunoreactive under the conditions employed. Microtubules were especially heavily immunolabeled, and this staining was seen even in processes that otherwise were only lightly immunoreactive (see, for example, Figs. 11, A, B; 13, A, B) . In addition, heavy immunoreactivity was often associated with the cytoplasmic surface of plasma membranes (Figs. 1 lA, 13A) . No special accumulation of immunoreaction product was noted on postsynaptic densities.
Immunoreactivity was found in glial cell bodies and processes (Figs. 5, 10, 14) . Immunolabeled glial cells had scant cytoplasm and elongate nuclei with coarse clumped chromatin (Fig. 14) . Intensely immunoreactive glial processes were an especially prominent feature of immunostaining in the hypothalamus. Much of the immunoreaction product in glial processes was Figure 12 . Electron micrograph of a spine (arrowhead) immunolabeled for the MARCUS urotein in cingulate cortex. Two unlabeled spines (s> are also present. Scale bar, 0.5 Frn.
present on the cytoplasmic surface of the plasma membrane (Fig. 15, A, c) . Immunoreactive glial processes enveloping preand postsynaptic elements (Fig. 15) or neuronal somata were also observed. In some instances, the glial membrane of these thin processes was entirely preserved (Fig. 14, inset) . In other instances, limiting membranes were difficult to resolve (see, for example, Fig. 15 ).
Discussion
The present paper demonstrates that the MARCKS protein, a major specific substrate for protein kinase C, is widespread throughout the brain and enriched in certain areas. The regional distribution of the protein observed by immunocytochemistry is consistent with that observed by quantitative immunoblot analysis. Many of the regions that are enriched for the MARCKS protein, such as the piriform and entorhinal cortices, most of the amygdaloid complex, the parabrachial nucleus, and the hypothalamus, are either part ofthe limbic system or are associated with the limbic system. In addition, the MARCKS protein is enriched in nuclei that project dilhtsely upon other regions and that may play a role in general modulation of target areas. These regions include the intralaminar nuclei, parts of the locus coeruleus, zona incerta, substantia nigra, ventral tegmental area, raphe nuclei, and much of the medial (magnocellular) subdivision of the medial geniculate nucleus.
At the ultrastructural level, immunoreactivity for the MARCKS protein is associated with microtubules in dendrites and axons, and with the plasma membrane in dendrites, axons and glial processes. Within nerve cells, immunoreactivity for the MARCKS protein shows a restricted distribution. Immunoreactivity is absent from large dendrites and from neuronal somata, but is present in small dendrites, axons and axon terminals. Few immunolabeled spines were detected, presumably reflecting that most of the MARCKS protein immunoreactivity is associated with microtubules, which are absent from dendritic spines.
The microtubule-associated immunoreactivity is particularly apparent in preparations that are minimally stained; in such cases, the immunoreactivity present in a neuritic profile is essentially confined to the microtubules (mitochondria and postsynaptic densities, for example, were not usually labeled). Although immunolabeling with the HRP technique is difficult to interpret at the electron microscope level because the immunoreaction product can diffuse to nearby surfaces, where it can be fixed in place by osmication, these data are suggestive of an association of the MARCKS protein with microtubules and a role for the protein in the organization of the cytoskeleton. The association of immunoreactivity with the plasma membrane in small dendrites, axons, and glial processes may represent the fraction of the MARCKS that is membrane bound. This fraction of the protein is likely to be myristoylated and could be translocated upon phosphorylation by protein kinase C (Wang et al., 1989) .
The MARCKS protein is enriched in higher-order dendritic branches of many or most neurons in immunoreactive regions. Thus, one role ofthe phosphoprotein may be related to functions specific to the higher-order branches of the dendritic tree. The axon terminal localizaton of the MARCKS protein is in agreement with the demonstration that the protein is present in synaptosomal fractions and growth cones (Katz et al., 1985; Dunkley et al., 1986; Hymand and Pfenninger, 1987; Wang et al., 1988) . In axon terminals, immunoreactivity is associated with synaptic vesicles. Because the vesicles are tightly packed and fill most of the volume of the terminal, it is not possible at present to determine whether there is a preferential association of immunoreactivity with vesicle membranes.
High levels of the MARCKS protein are present in glial cells that resemble microglial cells and astrocytes, which may be difficult to distinguish on morphological criteria alone (Miles and Chou, 1988) . Many glial cells that were immunoreactive for the MARCKS protein were clearly satellites of neurons (see, for example, Figs. 5, A, C, 10; 14) , a characteristic feature of microglial cells (Rio-Hortega, 1932; Cammermeyer, 1970) . In addition, most of the immunoreactive glial cells encountered at the electron microscopic level contained rod-shaped nuclei, clumped chromatin and scant cytoplasm, also characteristic of the microglial cell type (Rio-Hortega, 1932; Cammermeyer, 1970) . The MARCKS protein is also present in macrophages (Aderem et al., 1988) , a cell type closely related to microglia (for review, see Miles and Chou, 1988) , but its function in these cells is unknown.
Immunoreactive glial cell processes were densest in the hypothalamus, where they contributed very significantly to the overall level of immunostaining. Such glial cell processes immunoreactive for the MARCKS protein frequently enveloped pre-and postsynaptic elements, indicating that they may be able to modify the proximity of pre-and postsynaptic elements to each other. A similar role for glial cell intervention between axon endings and blood vessels has already been suggested for tanycytes in the hypothalamus (Lichtensteiger and Richards, 1975; Meister et al., 1988) and for pituicytes and secretory endings in the posterior pituitary gland (Tweedle and Hatton, 1987) .
It is of interest to compare the regional distribution of the MARCKS protein, a specific substrate for protein kinase C, with that of its phosphorylating enzyme. Protein kinase C appears to comprise several subspecies Knopf et al., 1986; Makowske et al., 1986; Ono et al., 1986a, b; Parker et al., 1986; Housey et al., 1987; Kubo et al., 1987; Ohno et al., 1987; Nishizuka, 1 SSS) , making the analysis of the localization of this enzyme complicated. Nonetheless, protein kinase C has been localized in rat brain by biochemical analysis of microdissected brain regions (e.g., Huang et al., 1987; Nelson et al., 1987; Walaas et al., 1983a, b) , by autoradiographic analysis of phorbol ester binding (Worley et al., 1986) and by immunocytochemistry (Girard et al., 1985 (Girard et al., , 1988 Wood et al., 1986; Kitano et al., 1987; Mochly-Rosen et al., 1987; Ase et al., 1988; Hashimoto et al., 1988; Huang et al., 1988; Saito et al., 1988) . The distribution of the MARCKS protein does not match exactly that of any of the known protein kinase C subspecies (Huang et al., 1987 (Huang et al., , 1988 Kitano et al., 1987; Mochly-Rosen et al., 1987; Saito et al., 1988) , the distribution of protein kinase C of undetermined subspecies (Girard et al., 1985; Wood et al., 1986) or that of total protein kinase C as determined by biochemical analysis (Walaas et al., 1983a, b) or by autoradiography of phorbol ester binding (Worley et al., 1985) . The greatest dissimilarity between the distribution of the MARCKS protein and that of protein kinase C is found in the hypothalamus, which displays high levels of the MARCKS protein but has low levels of total protein kinase C (Walaas et al., 1983a, b; Worley et al., 1986) . The widespread but different distribution of protein kinase C compared with the MARCKS protein suggests that the 2 proteins are not necessarily highly expressed in the same cells, consistent with the idea that the MARCKS protein subserves only one or a few of the many effects of protein kinase C.
In conclusion, the MARCKS protein is widespread in both neurons and glial cells throughout the rat CNS. The neuronal protein appears enriched in higher-order dendrites, axons, and axon terminals, while the glial protein is present throughout the cytosol. Ultrastructural analysis indicates that the protein may be partly associated with microtubules and that it could be involved in membrane-cytoskeleton interactions. The regional distribution of the protein is indicative of enrichment in neuronal systems that are subject to plastic changes. It will be interesting to anlayze the behavior of the MARCKS protein in identified brain cells under conditions where plastic changes are prevalent. Figure 13 . Electron micrograph of immunoreactivity for the MARCKS protein in small dendrites in cingulate cortex (A, c) and hypothalamus (B). Arrowheads point to immunoreactivity associated with dendritic microtubules. Some immunoreactivity is also associated with the inner surface of the dendritic membrane (for example, see arrow in A). S, example of an unlabeled spine; T, examples of unlabeled axon terminals. Scale bar, 0.5 pm. Figure 14 . Electron micrographs of glial immunoreactivity for the MARCKS protein in the cingulate cortex. Immunoreactivity is present in the cytoplasm of an elongated glial cell body (GCB) but not in the nucleus (Nu). The thin strip of immunoreactive cytoplasm (arrowhead) that intervenes between the glial cell and the unlabeled neuronal cell body (CB) strongly resembles the thin immunoreactive processes associated with dendrites and axon terminals (see Fig. 15 ). Inset, High-magnification photograph ofthe border between another immunoreactive glial cell (GCB) and an unlabeled neuron (CB). At this level of magnification and resolution, immunoreactivity seems to be confined to the cytoplasmic surface of the glial cell and is not present in the extracellular space. Scale bars, 0.5 pm. Figure 15 . Electron micrographs of immunolabeling for the MARCKS protein in profiles presumed to be glial processes because they often ensheath dendrites and axon terminals. Photomicrographs A and B show immunostaining in the hypothalamus, and C shows immunostaining in region CA 1 of the hippocampus. A, Presumed immunoreactive glial process (arrowhead) associated with an unlabeled axon terminal (7) and unlabeled dendrite (D). Strong immunoreactivity is present on the membrane (arrow). An immunoreactive dendrite (asterisk) is also present. B, An unlabeled dendrite (D) is almost surrounded (in the plane of section) by a glia-like immunoreactive process (arrowhead). C, Lightly immunoreactive profiles resembling glial processes (arrowheads) associated with unlabeled axon terminals (7') and dendrites (0). In the hippocampus, most of the immunoreaction product in presumed glial processes is associated with the membrane as shown in this photomicrograph. By comparison, more immunoreactivity was cytoplasmic in the presumed glial processes in the hypothalamus. Scale bars, 0.5 pm.
